Why the study?
How do sinus arrhythmia, atropine, and propranolol affect the standardized isoproterenol sensitivity test (CD25) in human subjects?
How do sinus arrhythmia, atropine, and propranolol affect the standardized isoproterenol sensitivity test (CD25) in human subjects?
The standardized isoproterenol sensitivity test using CD25 is a safe and accurate method for measuring beta-receptor responsiveness and beta-adrenergic blockade in humans.
Answers are grounded in this paper and cite their sources.
Validates CD25 specificity to beta-receptors independent of muscarinic effects; leaves open utility in current clinical beta-blockade assessment.
Isoproterenol hydrochloride sensitivity was measured from dose/response curves to rapid intravenous injections as the dose required to increase the heart rate by 25 beats per minute (chronotropic dose₂₅or CD₂₅). The most accurate assessment of CD₂₅was achieved by using the three shortest R-R intervals of the electrocardiogram to calculate heart rate before and after administration of isoproterenol to eliminate the effect of sinus arrhythmia. In ten subjects the CD₂₅appeared to increase with age between 21 and 35. Neither the chronotropic nor hypotensive effects of the CD₂₅for isoproterenol were affected by atropine sulfate, suggesting that vagal withdrawal does not contribute to the chronotropic effect of this dose. Propranolol hydrochloride increased the CD₂₅by acting as a competitive antagonist. The test procedure was safe, accurate, reproducible, and convenient for measuring both β-receptor responsiveness and β-adrenergic blockade in man.
No takes yet. Share an insight, caveat, or question.
Clifton R. Cleaveland (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: